首页> 外文期刊>Journal of Obstetrics and Gynecology of India >Preoperative Use of 10-mg Metoclopramide and 50-mg Dimenhydrinate in the Prophylaxis of Postoperative Nausea and Vomiting in Elective Caesarean Births: A Prospective Randomized Clinical Study
【24h】

Preoperative Use of 10-mg Metoclopramide and 50-mg Dimenhydrinate in the Prophylaxis of Postoperative Nausea and Vomiting in Elective Caesarean Births: A Prospective Randomized Clinical Study

机译:术前使用10 mg甲氧氯普胺和50 mg地苯海明预防预防性剖腹产术后恶心和呕吐的前瞻性随机临床研究

获取原文
       

摘要

Background The purpose of this study was to assess the efficacy and outcomes of preoperative prophylactic metoclopramide and dimenhydrinate use in elective cesarean births. Methods Participants ( n =?84) scheduled for elective cesarean births were randomized equally into placebo (10?cc 0.9?% NaCl), 10-mg metoclopramide or 50-mg dimenhydrinate groups. Oral alimentation was prohibited 8?h before the surgery; however, patients continued drinking water until 4?h before surgery. Placebo and antiemetics were administered 1?h before the anticipated procedure in a 5-ml syringe. In metoclopramide and dimenhydrinate group, an ampoule of the agents was completed to 5?ml by adding 0.9?% NaCl. In the control group 5?ml of 0.9?% NaCl was used. All prophylactic agents were administered intramuscularly. All patients received a general anesthesia. The placebo group (control group) was compared with the metoclopramide and dimenhydrinate groups. Results Demographic data including maternal age, height, weight, body mass index, gravidity, parity, miscarriage, induced abortion, the number of offspring, and the medical history did not show significant differences among the three groups. Postoperative nausea, vomiting, and the use of rescue medication ratios were significantly lower in metoclopramide and dimenhydrinate groups compared with the placebo group ( p p >?0.05). Conclusion Dimenhydrinate and metoclopramide significantly decrease postoperative nausea, vomiting, and the need for rescue antiemetic medication. Both agents have similar efficacy and may be used as an alternative to each other.
机译:背景技术这项研究的目的是评估选择性剖宫产术前预防性胃复安和地海明的使用效果和结果。方法将计划进行剖宫产的参加者(n =?84)均等地随机分为安慰剂(10?cc 0.9 %% NaCl),10-mg甲氧氯普胺或50-mg苯海马汀组。手术前8小时禁止口服营养。但是,患者在手术前持续喝水直到4?h。在预期的操作之前,在5毫升注射器中1小时服用安慰剂和止吐药。在甲氧氯普胺和联苯海拉明组中,通过加入0.9%的NaCl将安瓿瓶中的试剂安瓶至5毫升。在对照组中,使用5ml的0.9%NaCl。所有预防剂均通过肌肉注射。所有患者均接受全身麻醉。安慰剂组(对照组)与甲氧氯普胺和苯海拉明组进行比较。结果人口统计学数据,包括孕产妇年龄,身高,体重,体重指数,妊娠率,胎次,流产,人工流产,后代数量以及病史,在三组之间没有显着差异。与安慰剂组相比,甲氧氯普胺和苯海拉明组的术后恶心,呕吐和使用急救药物的比率显着降低(p p>?0.05)。结论地苯海明和胃复安可显着减少术后恶心,呕吐和急救止吐药物的需求。两种药物具有相似的功效,可以彼此替代。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号